Medicina y salud
Disciplina temática
Klinikum der Universität München
Múnich, AlemaniaPublicaciones en colaboración con investigadores/as de Klinikum der Universität München (53)
2024
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
-
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis
Schizophrenia bulletin, Vol. 50, Núm. 3, pp. 496-512
-
Biallelic loss-of-function variants of ZFTRAF1 cause neurodevelopmental disorder with microcephaly and hypotonia
Genetics in Medicine, Vol. 26, Núm. 7
-
Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS
Early Intervention in Psychiatry, Vol. 18, Núm. 4, pp. 255-272
-
Dual disorder: does expert clinical experience support the rationale for cariprazine use?
European Review for Medical and Pharmacological Sciences, Vol. 28, Núm. 5, pp. 2095-2106
-
Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease
Nature Genetics, Vol. 56, Núm. 1, pp. 27-36
-
Penumbral Rescue by normobaric O = O administration in patients with ischemic stroke and target mismatch proFile (PROOF): Study protocol of a phase IIb trial
International Journal of Stroke, Vol. 19, Núm. 1, pp. 120-126
-
Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 42, Núm. 2, pp. 205-217
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Author Correction: Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2) (npj Parkinson's Disease, (2023), 9, 1, (100), 10.1038/s41531-023-00526-9)
npj Parkinson's Disease
-
Corrigendum to “Dissecting the genetic heterogeneity of gastric cancer” (eBioMedicine (2023) 92, (S2352396423001810), (10.1016/j.ebiom.2023.104616))
eBioMedicine
-
Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
npj Parkinson's Disease, Vol. 9, Núm. 1
-
Dissecting the genetic heterogeneity of gastric cancer
eBioMedicine, Vol. 92
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
-
Genetic Architecture of Ischaemic Strokes after COVID-19 Shows Similarities with Large Vessel Strokes
International Journal of Molecular Sciences, Vol. 24, Núm. 17
-
Identifying Early Infections in the Setting of CRS with Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHL
HemaSphere, Vol. 7, Núm. 4, pp. E858
-
Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations
Blood
-
The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL
American Journal of Hematology, Vol. 98, Núm. 11, pp. 1699-1710
-
Thrombectomy versus Medical Management for Isolated Anterior Cerebral Artery Stroke: An International Multicenter Registry Study
Radiology, Vol. 307, Núm. 2
2022
-
A functional neuroimaging association study on the interplay between two schizophrenia genome-wide associated genes (CACNA1C and ZNF804A)
European Archives of Psychiatry and Clinical Neuroscience, Vol. 272, Núm. 7, pp. 1229-1239